Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018

Adv Ther. 2022 Nov;39(11):5300. doi: 10.1007/s12325-022-02255-6.

Authors

Yifei Liu¹, Martha Skup², Min Yang³, Cynthia Z Qi³, Eric Q Wu³

Affiliations

¹ University of Missouri-Kansas City School of Pharmacy, 1228 Health Sciences Building, 2464 Charlotte Street, Kansas City, MO, 64108, USA. liuyif@umkc.edu.
² AbbVie, Chicago, IL, USA.
³ Analysis Group, Inc., Boston, MA, USA.

No abstract available

Publication types

Published Erratum